Fibrobiologics Inc (FBLG)

Currency in USD
0.98
-0.04(-3.92%)
Real-time Data·
Advertisement
FBLG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.981.06
52 wk Range
0.2412.80
Key Statistics
Prev. Close
1.02
Open
1.04
Day's Range
0.98-1.06
52 wk Range
0.24-12.8
Volume
87.94K
Average Volume (3m)
194.34K
1-Year Change
-90.8274%
Book Value / Share
0.86
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FBLG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.50
Upside
+1,175.51%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Fibrobiologics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 12.50
(+1,175.51% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy6.00+512.24%8.00Maintain04/08/2026
Maxim Group
Hold---Downgrade04/05/2026
H.C. Wainwright
Buy8.00+716.33%4.00Maintain16/04/2026
D. Boral Capital
Hold---Downgrade26/03/2026
H.C. Wainwright
Buy4.00+308.16%5.00Maintain26/02/2026

Earnings

Latest Release
31/07/2026
EPS / Forecast
-0.66 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare FBLG to Peers and Sector

Metrics to compare
FBLG
Peers
Sector
Relationship
P/E Ratio
−0.4x−8.3x−0.4x
PEG Ratio
−0.01−0.950.00
Price/Book
1.5x6.0x2.6x
Price / LTM Sales
-18.2x3.0x
Upside (Analyst Target)
-56.1%50.7%
Fair Value Upside
Unlock−9.2%7.2%Unlock

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
59.88K1.11%51.98K
Other Institutional Investors
1.33M24.70%1.16M
Public Companies & Retail Investors
4.01M74.19%3.48M
Total
5.4M100.00%4.69M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Golden Knight Incorporated, L.P.6.25%337,493293
Armistice Capital Master Fund Ltd.4.81%259,434225

People Also Watch

1.25
LZMH
+7.76%
1.02
ONEG
-1.92%
3.50
SOWG
+0.86%

FAQ

What Is the Fibrobiologics (NASDAQ: FBLG) Share Price Today?

The Fibrobiologics stock price today is 0.98 USD.

What Stock Exchange Does Fibrobiologics (FBLG) Trade On?

Fibrobiologics is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Fibrobiologics?

The stock symbol (also called a 'ticker') for Fibrobiologics is "FBLG."

What Is the Current Fibrobiologics Market Capitalisation?

As of today, Fibrobiologics (NASDAQ: FBLG) market cap is 6.79M USD.

What Is Fibrobiologics's (FBLG) Earnings Per Share (TTM)?

The Fibrobiologics EPS is currently -4.77 (Trailing Twelve Months).

When Is the Next Fibrobiologics Earnings Date?

Fibrobiologics's next earnings report will be released on 03/08/2026.

Is FBLG a Buy or Sell From a Technical Analyst Perspective?

Based on today's Fibrobiologics moving averages and other technical indicators, the daily buy/sell signal for FBLG stock is Strong Buy.

How Many Times Has Fibrobiologics Stock Split?

Fibrobiologics has split 1 times. (See the FBLG stock split history page for full effective split date and price information.)

What is the current trading status of Fibrobiologics (NASDAQ: FBLG)?

As of 07/08/2026, Fibrobiologics (FBLG) is trading at a share price of 0.98 USD, with a previous close of 1.02 USD. The stock has fluctuated within a day range of 0.98 USD to 1.06 USD, while its 52-week range spans from 0.24 USD to 12.80 USD.

What Is Fibrobiologics (FBLG) Price Target According to Analysts?

The average 12-month price target for Fibrobiologics is 12.50 USD, with a high estimate of 19 USD and a low estimate of 6 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +1,175.51% Upside potential.

What Is the FBLG Premarket Price?

FBLG's last pre-market stock price is 1.00 USD. The pre-market share volume is 890.00, and the stock has decreased by -0.02, or -1.96%.

What Is the FBLG After Hours Price?

FBLG's last after hours stock price is 0.97 USD, the stock has decreased by -0.05, or -4.89%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.